Tevogen Bio Holdings Overview
Latest ROE for Tevogen Bio Holdings: 243.15% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow243.15%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for TVGN is 243.15%. That is above the sector sector average of -5.68%. Investors often review this figure alongside Tevogen Bio Holdings's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TVGN currently prints 243.15% for ROE, while the sector average sits near -5.68%. That is roughly 4378.3% above the sector mean. Large gaps often invite a closer look at Tevogen Bio Holdings's growth, margins, and balance sheet.
Return on Equity shows how effectively Tevogen Bio Holdings converts resources into returns. At 243.15%, TVGN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TVGN's ROE (243.15%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
